Core Viewpoint - The company, Hangzhou High-tech (300478.SZ), announced a potential change in control as the controlling shareholder, Zhejiang Donghang Holding Group Co., Ltd., and the actual controller, Hu Min, are planning to transfer 19.03% of the company's total shares to a counterparty, which may lead to a change in control [1] Summary by Relevant Sections - **Control Change Notification** - The company received a notification regarding the planned transfer of 19.03% of its total shares, which may result in a change of control [1] - **Shareholder Information** - The controlling shareholder is Zhejiang Donghang Holding Group Co., Ltd., and the actual controller is Hu Min [1] - **Stock Suspension** - The company's stock will be suspended from trading starting June 30, 2025, with an expected suspension period of no more than 2 trading days [1] - **Counterparty Profile** - The counterparty involved in the share transfer primarily operates in the technology promotion and application service industry [1]

Group 1 - The controlling shareholder of Renfu Pharmaceutical, Wuhan Contemporary Technology Industry Group, has received court approval for its restructuring plan on April 25, 2025 [1] - As of June 27, 2025, the transfer of 387 million shares of Renfu Pharmaceutical from Contemporary Technology to the new shareholders has been completed, with the transfer date being June 26, 2025 [1] - After the share transfer, Zhaoshang Biomedical directly holds 97.93 million shares of Renfu Pharmaceutical, accounting for 6% of the total share capital [1] Group 2 - Zhaoshang Biomedical has obtained the corresponding partnership interests from the limited partnership, and the trust plan Spring Mud No. 1 has delegated its voting rights of 11.70% of the shares to Zhaoshang Biomedical [2] - As of the announcement date, Zhaoshang Biomedical controls a total of 403 million ordinary shares, representing 24.70% of the voting rights of the company [2] - Zhaoshang Biomedical needs to complete the reorganization of the board of directors to establish control, after which the controlling shareholder will change to Zhaoshang Biomedical and the actual controller will change to China Merchants Group [2]

本次权益变动涉及股份过户登记手续已办理完成，招商生科已取得有限合伙企业生科投资发展的相应的 合伙财产份额及信托计划春泥1号的相应份额，春泥1号已将所持公司11.70%股票表决权委托给招商生 科。截至公告披露之日，招商生科通过直接持有、通过其控制的有限合伙企业间接持有和接受信托计划 表决权委托方式合计控制公司4.03亿股普通股(占公司总股本的24.70%)表决权;招商生科尚需完成公司董 事会改组以形成控制，董事会改组等事项完成后，公司控股股东将变更为招商生科，实际控制人将变更 为招商局集团有限公司。 2025年6月27日，当代科技管理人收到中国证券登记结算有限责任公司出具的《证券过户登记确认 书》，当代科技所持人福医药3.87亿股已通过司法划转方式办理完成股份过户登记手续，过户日期为 2025年6月26日。本次股份过户完成后，招商生科直接持有人福医药9793.36万股股份，占人福医药总股 本的6%，生科投资发展持有人福医药9793.36万股股份，占人福医药总股本的6%。春泥1号获得并持有 人福医药1.91亿股股票，占人福医药总股本的11.70%，并已将对应的全部表决权委托给招商生科。 人福医药（600079）( ...

面临退市风险的*ST亚振，再次因股价暴涨而停牌核查。 6月26日晚间，*ST亚振(603389.SH)公告称，公司股票于2025年6月17日至26日收盘价格涨幅偏离值累计达到29.43%，短期涨幅与同期上证指数、家具制造业 存在严重偏离。 公告表示，为维护投资者利益，公司将就股票交易情况进行核查。经申请，公司股票自2025年6月27日开市起停牌，自披露核查公告后复牌，预计停牌时间 不超过5个交易日。 | 证券代码 证券简称 | | 停复理类型 | 停牌起始日 | 은 문 | 伊兰家庭处 | 复問日 | | --- | --- | --- | --- | --- | --- | --- | | | | | | 第同 | | | | 603389 | *ST 亚提 | A 股 停牌 | 2025/6/27 | | | | 在业绩延续颓势的情况下，本轮股价暴涨或与公司控制权变更密切相关。 2025年4月24日，*ST亚振发布公告表示，其控股股东上海亚振投资有限公司（以下简称"亚振投资"）及公司实控人高伟、户美云、高银楠与吴涛及其一致 行动人范伟浩分别签署《股份转让协议》。亚振投资向吴涛、范伟浩转让7882.55万股 ...

Core Viewpoint - The company, Songyang Resources, announced a potential change in control due to the major shareholder's plan to transfer shares, leading to a suspension of its stock trading [2][4]. Group 1: Control Change Announcement - On June 26, Songyang Resources disclosed that its controlling shareholder and actual controller, Wang Zhuangpeng, is planning a significant share transfer that may result in a change of control [2][4]. - The company's stock will be suspended from trading starting June 27, with the suspension expected to last no more than two trading days [4]. Group 2: Shareholding Structure - As of the end of Q1, Wang Zhuangpeng holds 42,730,500 shares, representing 20.88% of the total share capital, making him the largest shareholder [5]. - The total shareholding of the top ten shareholders accounts for 35.11% of the total share capital, with a combined market value of approximately 9.39 billion [5]. Group 3: Company Overview - Songyang Resources primarily engages in the research, production, and sales of environmentally friendly recycled paper, including high-strength corrugated paper, specialty paper, and whiteboard paper [6]. - The company has been facing long-term performance pressure, with net profits declining for three consecutive years and unstable revenue performance [7]. Group 4: Future Plans - The company aims to reduce costs and improve efficiency through technological upgrades in 2025, with a focus on stabilizing production capacity and achieving profitability [7].

Core Viewpoint - The stock price of Shenzhen Feima International Supply Chain Co., Ltd. (Feima International) experienced significant fluctuations due to a planned change in control, with a notable increase followed by a slight decline in the following days [1][4]. Stock Price Movement - On June 24, Feima International opened high and saw a price increase of 9.88%, closing at 2.67 CNY per share [1] - The stock continued to rise on June 25, reaching a peak of 2.8 CNY per share, marking a 60-day high, before closing at 2.7 CNY [1] - On June 26, the stock price fell to 2.64 CNY, a decrease of 2.22% from the previous day [1][3]. Control Change and Investment Agreement - Feima International received a notice from its indirect controlling shareholder, New Hope Investment Group, regarding an investment intention agreement with several parties, including Zhangzhou High-tech Zone Gaoxin Venture Capital Partnership [4]. - The agreement involves a potential transfer of shares and investment in Feima International, with Gaoxin Venture Capital aiming to acquire at least 66.89% of the shares in the target company [6]. Historical Context of Shareholding - New Hope Investment Group and Baijingli Technology hold significant stakes in the controlling entity, New Zengding, which previously acquired a 29.9% stake in Feima International in 2021 [4][9]. - New Zengding's entry was initially as a "firefighter" to stabilize Feima International, committing to provide financial support and meet performance targets [9]. Performance and Financial Obligations - New Zengding's performance commitments have not been met, with only 20% of the promised net profit achieved from 2022 to 2024, leading to a required cash compensation of 437 million CNY [9][10]. - The company's financial performance has deteriorated, with a 12.13% decline in revenue and a significant drop in net profit in the first quarter of the current year [9][10]. Upcoming Developments - The agreement's exclusivity period is set for one month from the signing date, indicating that developments regarding the share transfer and control change will be clarified soon [12].

中国基金报记者 南深 陷入长子和继母内斗、业绩从下滑到亏损的杉杉股份，实控人方面的持股持续遭到拍卖。 【导读】牛散 魏巍 通过司法拍卖，拿下杉杉股份1300万股 6月25日晚，杉杉股份发布公告，自然人 魏巍以每股8.42元（ 最新价为9.78元/股 ）、总价 1.09亿 元， 通过司法拍卖平台拿下公司 1300 万 股 股份，而股份被拍卖方正是杉杉股份间接控股股东杉杉控股。 今年以来，杉杉股份实控人方面的持股由于司法拍卖、可交债转股等原因，处于持续下降过程中，此次拍卖后，其最新持股比例下降到 26.36%。 目前杉杉股份大股东杉杉集团等已经启动重整程序，后续公司存在 控制权 变更的预期。 牛散魏巍擅长潜伏ST股 杉杉股份于 2025年5月27日披露了《关于间接控股股东部分持股将被司法处置的提示性公告》，上海金融法院于2025年6月24日在上海证 券交易所大宗股票司法协助执行平台（ 以下简称 司法执行平台）对杉杉控股持有的 1300万 股 公司 股票公开进行股票司法处置。 6月25日， 司法执行平台的成交结果公告显示，竞买人魏巍以每股单价8.42元（ 较杉杉股份6月25日收盘价9.78元/股约折价14%）、 总 ...

Core Viewpoint - Zhang Xiaoqing Co., Ltd. is facing significant challenges due to the restructuring of its controlling shareholder, Hangzhou Zhang Xiaoqing Group, which has entered a formal reorganization process, leading to uncertainties regarding the company's control and future operations [1][3]. Group 1: Shareholder Restructuring - The Hangzhou Zhang Xiaoqing Group has been accepted for reorganization by the court, creating uncertainty about its ability to successfully complete the process [1]. - The potential for changes in the control of Zhang Xiaoqing Co., Ltd. exists due to the restructuring of its controlling shareholder [1][3]. - The company has previously reported that the restructuring of its indirect controlling shareholder, Fuchun Holdings Group, would not materially affect its daily operations [3]. Group 2: Debt Crisis - Zhang Xiaoqing Group has been embroiled in a debt crisis, with overdue debts totaling 5.925 billion yuan as of March 19, 2025 [5]. - The group has faced legal actions due to its inability to repay loans, including a 128 million yuan loan and a 300 million yuan loan, leading to multiple parties being listed as defendants [4][5]. - The company's shares have been subject to judicial auction due to the debt crisis, with significant portions of its holdings being sold off [6][7]. Group 3: Financial Performance - The company experienced a decline in net profit by 47.3% in 2022, with revenues of 827 million yuan, and a further decline in 2023 with revenues of approximately 811 million yuan, down 1.82% year-on-year [11][12]. - Despite the challenges, the company reported a revenue increase of 11.87% in 2024, reaching 908 million yuan, and a 14.54% increase in net profit [12]. Group 4: Brand Reputation Issues - Zhang Xiaoqing has faced significant public relations challenges, including a viral incident involving product quality that led to negative consumer sentiment [10][11]. - The company has been penalized for engaging in fraudulent practices to manipulate sales figures, which has further damaged its reputation [11].

Group 1 - The core point of the article is the change of control in Anhui Shenjian New Materials Co., Ltd., where Wuhu Yuanda Chuangye Investment Co., Ltd. will become the controlling shareholder through a share transfer agreement and voting rights entrustment [2][3] - The controlling shareholder Liu Zhijian and his associates signed a share transfer agreement to transfer a total of 79.2 million shares, representing 8.33% of the company's total share capital [2] - Liu Zhijian will entrust all voting rights of his remaining 120,415,980 shares (approximately 12.66% of the total share capital) to Wuhu Yuanda Chuangye for a period of three years [2] Group 2 - The acquisition of control by Wuhu Yuanda Chuangye has received preliminary approval from the Anhui Provincial State-owned Assets Supervision and Administration Commission [3] - The agreement will take effect upon approval from relevant regulatory authorities and the completion of share transfer procedures [3] - The company will continue to monitor the situation and fulfill its information disclosure obligations as required by law [3]

证券代码：600288 证券简称：大恒科技 编号：临 2025-023 大恒新纪元科技股份有限公司 关于控股股东、实际控制人股份将被司法拍卖的进展 公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大 遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： ? 截至本公告披露日，控股股东、实际控制人郑素贞女士持有大恒新纪元 科技股份有限公司（以下简称"公司"或"大恒科技"）股份总数 129,960,000 股无限售流通股，其中被司法冻结 129,960,000 股，占其所持公司股份的 100%， 占公司总股本的 29.75%。本次将被司法拍卖股份占其所持公司股份数量的 ? 本次司法拍卖事项涉及公司控股股东、实际控制人，若上述公司股份全 部被司法拍卖，将导致公司控制权发生变更，目前公司经营活动正常，本次事项 暂不会对公司的生产经营产生重大不利影响，亦不会导致公司股权分布不具备上 市条件。 ? 本次司法拍卖事项尚处于公示阶段，后续将可能涉及竞拍、缴款、股权 变更过户等环节，拍卖结果尚存在不确定性，公司将持续关注上述事项的进展情 况，并依据相关规定及时履行信息披露义 ...